MARKET

CLVLY

CLVLY

Clinuvl Phrmaceu
OTCPK
7.36
-0.16
-2.13%
Closed 09:53 03/20 EDT
OPEN
7.36
PREV CLOSE
7.52
HIGH
7.36
LOW
7.36
VOLUME
650
TURNOVER
4.78K
52 WEEK HIGH
11.36
52 WEEK LOW
6.80
MARKET CAP
368.45M
P/E (TTM)
15.39
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CLVLY last week (0310-0314)?
Weekly Report · 4d ago
Weekly Report: what happened at CLVLY last week (0303-0307)?
Weekly Report · 03/10 11:59
Clinuvel Introduces Groundbreaking Vitiligo Program at the World’s Biggest Dermatology Meeting, AAD 2025
Barchart · 03/03 20:17
Weekly Report: what happened at CLVLY last week (0224-0228)?
Weekly Report · 03/03 11:58
Weekly Report: what happened at CLVLY last week (0217-0221)?
Weekly Report · 02/24 11:57
Weekly Report: what happened at CLVLY last week (0210-0214)?
Weekly Report · 02/17 11:54
Weekly Report: what happened at CLVLY last week (0203-0207)?
Weekly Report · 02/10 11:46
Weekly Report: what happened at CLVLY last week (0127-0131)?
Weekly Report · 02/03 11:53
More
About CLVLY
Clinuvel Pharmaceuticals Limited is an Australia-based global specialty pharmaceutical company. The Company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the USA, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company’s pharmaceuticals product development includes PRENUMBRA and NEURACTHEL. Its PhotoCosmetics product development includes CYACELLE and DNA Repair Assist and Melanogenesis. PRENUMBRA is a formulation of afamelanotide designed to provide a flexible dose in identified patient groups. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH).

Webull offers Clinuvel Pharmaceuticals Ltd (ADR) stock information, including OTCPK: CLVLY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLVLY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLVLY stock methods without spending real money on the virtual paper trading platform.